kicked off on Monday, with Aquestive Therapeutics Inc (NASDAQ: AQST) stock price down -4.13% from the previous day of trading, before settling in for the closing price of $5.09. AQST’s price has ranged from $1.25 to $6.23 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -4.81%. Meanwhile, its annual earnings per share averaged -231.87%. With a float of $79.37 million, this company’s outstanding shares have now reached $91.06 million.
Let’s determine the extent of company efficiency that accounts for 135 employees.
Aquestive Therapeutics Inc (AQST) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Aquestive Therapeutics Inc is 12.84%, while institutional ownership is 40.20%. The most recent insider transaction that took place on Mar 15 ’24, was worth 300,000. In this transaction Chief Innovation/Tech Officer of this company sold 50,000 shares at a rate of $6.00, taking the stock ownership to the 984,476 shares. Before that another transaction happened on Mar 08 ’24, when Company’s Chief Innovation/Tech Officer sold 25,000 for $5.19, making the entire transaction worth $129,685. This insider now owns 1,040,371 shares in total.
Aquestive Therapeutics Inc (AQST) Recent Fiscal highlights
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.03 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -231.87% per share during the next fiscal year.
Aquestive Therapeutics Inc (NASDAQ: AQST) Trading Performance Indicators
Here are Aquestive Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.35, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.49 in one year’s time.
Technical Analysis of Aquestive Therapeutics Inc (AQST)
Looking closely at Aquestive Therapeutics Inc (NASDAQ: AQST), its last 5-days average volume was 1.52 million, which is a drop from its year-to-date volume of 1.82 million. As of the previous 9 days, the stock’s Stochastic %D was 74.45%. Additionally, its Average True Range was 0.31.
During the past 100 days, Aquestive Therapeutics Inc’s (AQST) raw stochastic average was set at 86.56%, which indicates a significant increase from 65.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.88% in the past 14 days, which was higher than the 72.65% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.04, while its 200-day Moving Average is $3.36. However, in the short run, Aquestive Therapeutics Inc’s stock first resistance to watch stands at $5.12. Second resistance stands at $5.35. The third major resistance level sits at $5.55. If the price goes on to break the first support level at $4.69, it is likely to go to the next support level at $4.49. Now, if the price goes above the second support level, the third support stands at $4.26.
Aquestive Therapeutics Inc (NASDAQ: AQST) Key Stats
With a market capitalization of 444.37 million, the company has a total of 91,039K Shares Outstanding. Currently, annual sales are 50,580 K while annual income is -7,870 K. The company’s previous quarter sales were 20,100 K while its latest quarter income was -2,750 K.
